glimepiride has been researched along with Albuminuria in 5 studies
glimepiride: structure given in first source
Albuminuria: The presence of albumin in the urine, an indicator of KIDNEY DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mean composite kidney disease progression occurred in 135 (10." | 3.30 | Comparative Effects of Glucose-Lowering Medications on Kidney Outcomes in Type 2 Diabetes: The GRADE Randomized Clinical Trial. ( Bebu, I; de Boer, IH; Ghosh, A; Inzucchi, SE; Ismail-Beigi, F; McGill, JB; Mudaliar, S; Schade, D; Steffes, MW; Tamborlane, WV; Tan, MH; Wexler, DJ; Younes, N, 2023) |
| "In participants with type 2 diabetes, the incidences of microvascular complications and death were not materially different among the four treatment groups." | 3.11 | Glycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular Outcomes. ( Bebu, I; Burch, HB; Buse, JB; Cherrington, AL; Fortmann, SP; Green, JB; Kahn, SE; Kirkman, MS; Krause-Steinrauf, H; Lachin, JM; Larkin, ME; Nathan, DM; Phillips, LS; Pop-Busui, R; Steffes, M; Tiktin, M; Tripputi, M; Wexler, DJ; Younes, N, 2022) |
| "Ninety-eight patients with type 2 diabetes and a fasting blood glucose (FBG) levels between 7." | 2.75 | Hydrochloride pioglitazone decreases urinary cytokines excretion in type 2 diabetes. ( Chen, Y; Hu, YY; Wu, FZ; Ye, SD; Zhao, LL; Zheng, M, 2010) |
| "glimepiride were evaluated in normoalbuminuric patients with type 2 diabetes mellitus." | 2.74 | Nephro- and neuroprotective effects of rosiglitazone versus glimepiride in normoalbuminuric patients with type 2 diabetes mellitus: a randomized controlled trial. ( Bob, F; Bozdog, G; Dragos Jianu, C; Dumitrascu, V; Gadalean, F; Giju, S; Gluhovschi, C; Gluhovschi, G; Ianculescu, C; Marian, R; Petrica, L; Petrica, M; Ursoniu, S; Velciov, S; Vlad, A, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nathan, DM | 1 |
| Lachin, JM | 1 |
| Bebu, I | 2 |
| Burch, HB | 1 |
| Buse, JB | 1 |
| Cherrington, AL | 1 |
| Fortmann, SP | 1 |
| Green, JB | 1 |
| Kahn, SE | 1 |
| Kirkman, MS | 1 |
| Krause-Steinrauf, H | 1 |
| Larkin, ME | 1 |
| Phillips, LS | 1 |
| Pop-Busui, R | 1 |
| Steffes, M | 1 |
| Tiktin, M | 1 |
| Tripputi, M | 1 |
| Wexler, DJ | 2 |
| Younes, N | 2 |
| de Boer, IH | 1 |
| Ghosh, A | 1 |
| Inzucchi, SE | 1 |
| McGill, JB | 1 |
| Mudaliar, S | 1 |
| Schade, D | 1 |
| Steffes, MW | 1 |
| Tamborlane, WV | 1 |
| Tan, MH | 1 |
| Ismail-Beigi, F | 1 |
| Petrica, L | 1 |
| Petrica, M | 1 |
| Vlad, A | 1 |
| Dragos Jianu, C | 1 |
| Gluhovschi, G | 1 |
| Ianculescu, C | 1 |
| Dumitrascu, V | 1 |
| Giju, S | 1 |
| Gluhovschi, C | 1 |
| Bob, F | 1 |
| Ursoniu, S | 1 |
| Gadalean, F | 1 |
| Velciov, S | 1 |
| Bozdog, G | 1 |
| Marian, R | 1 |
| Hu, YY | 1 |
| Ye, SD | 1 |
| Zhao, LL | 1 |
| Zheng, M | 1 |
| Wu, FZ | 1 |
| Chen, Y | 1 |
| Kida, Y | 1 |
| Sato, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study[NCT01794143] | Phase 3 | 5,047 participants (Actual) | Interventional | 2013-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 trials available for glimepiride and Albuminuria
| Article | Year |
|---|---|
Glycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular Outcomes.
Topics: Albuminuria; Blood Glucose; Cardiovascular Diseases; Comparative Effectiveness Research; Diabetes Co | 2022 |
Comparative Effects of Glucose-Lowering Medications on Kidney Outcomes in Type 2 Diabetes: The GRADE Randomized Clinical Trial.
Topics: Adult; Albuminuria; Diabetes Mellitus, Type 2; Disease Progression; Female; Glomerular Filtration Ra | 2023 |
Nephro- and neuroprotective effects of rosiglitazone versus glimepiride in normoalbuminuric patients with type 2 diabetes mellitus: a randomized controlled trial.
Topics: Albuminuria; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hypoglycemic Agents; | 2009 |
Hydrochloride pioglitazone decreases urinary cytokines excretion in type 2 diabetes.
Topics: Adult; Albuminuria; Blood Glucose; Blood Pressure; Chemokine CCL2; Creatinine; Cytokines; Diabetes M | 2010 |
1 other study available for glimepiride and Albuminuria
| Article | Year |
|---|---|
Pioglitazone vs glimepiride and carotid intima-media thickness.
Topics: Albuminuria; Atherosclerosis; Carotid Arteries; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Huma | 2007 |